Relationship between Canine Lymphocyte AgNOR Counts and Haematological Indices of Health

Open access

Abstract

A modified agyrophil technique was applied to peripheral blood smears to determine the mean AgNOR counts (MAC) of lymphocytes and ultimately assess the state of the lymphoid system in various clinical conditions of dogs. Fifty dogs, from clinically normal to pets with leukaemia, presented to the Veterinary Teaching Hospital, were recruited. Blood smears from each dog were stained with routine Romanowsky and modified agyrophil stains. Signalment, clinical diagnoses and hematologic parameters of the dogs were related to the MAC. An AgNOR proliferative index (AgPI) — percentage of lymphocytes with 3 or more AgNORs, was determined, and correlated with MAC. The statistical significance was determined at P < 0.05. MAC ranged from 1.17 in clinically healthy patients to 6.00 in leukaemic patients. The MAC was 2.00 in patients (n = 26) with lymphocyte counts within reference intervals (900—2400 per microliter); 2.23 in patients (n = 4) with lymphopenia; 2.18 in patients with lymphocytosis (n = 18) and 4.73 in patients (n = 4) with lymphocytic leukemia. Also, the MAC was 2.00 in non-anemic dogs while it was 2.47, 2.49 and 3.06 in patients with mild, moderate and severe anaemia, respectively. The MAC correlated strongly with AgPI (r = 0.91). The ancillary AgNOR technique provides a cheaper, more rapid and sensitive tool than routine lymphocyte counts in assessing the state of lymphoid proliferation in a variety of conditions in the dog.

1. Bukhari M. H., Niazi S., Khan S. A., Hashmi I., Perveen S., 2007: Modified method of AgNOR staining for tissue interpretation in histopathology. Int. J. Exp. Pathol., 88, 47—53.

2. Cronin, K., Loftus, B. M., Dervan, P. A., 1989: Are AgNORs useful in distinguishing follicular hyperplasia from follicular lymphoma ? J. Clin. Pathol., 42, 1267—1268.

3. Derenzini, M., Trere, D., 1994: AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralblatt fűr Pathologie, 14, 7—10.

4. Garcia-Moreno, L. M., Cimadevilla, J. M., Gonzalez-Pardo, H., Arias, J. L., 2000: Functional differences between ventral and dorsal hippocampus revealed with AgNOR staining. Psicothema, 12, 293—295.

5. Goodpasture, C., Blossom, S. E., 1975: Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma, 53, 37.

6. Imamoglu, N., Demirtas, H., Donmez-Altuntas, H., Ilten, A., 2005: Higher NORs expression in lymphocyte of trisomy 21 babies/children: In vivo evaluation. Micron, 36, 503—507.

7. Imamoglu, N., Eroz, R., Canatan, H., Demirtas, H., Saatci, C., 2016: Nuclear AgNOR protein enhancement in nucleoplasms of peripheral blood lymphocytes of babies/children with Down syndrome. Microscopy Res. Tech., 79,133—139.

8. Jelisijevic, T., Jovanovic, M., Knezevic, M., Aleksic-Kovacecic, S., 2003: Quantitative and qualitative analysis of AgNOR in benign and malignant canine mammary gland tumours. Acta Veterinaria (Beograd), 53, 353—360.

9. Johnson, G. C., Miller, M. A., Ramos-Vara, J. A., 1995: Comparison of agyrophilic nucleolar organizer regions and mitotic index in distinguishing benign from malignant canine smooth muscle tumours in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J. Vet. Diagn. Investigation, 7, 127—136.

10. Lindner, L. E., 1993: Improvements in silver-staining technique for nucleolar organizer regions. J. Histochem. Cytochem., 41, 439—445.

11. Mamaev, N. N., Salogub, G. N., Nefedov, I. B., 1997: Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. J. Clin. Pathol. Mol. Pathol., 50, 92—95.

12. Manu, V., Rajram, T., Rai R., 2006: Value of silver binding nucleolar organizer regions in squamous cell carcinomas of upper aero-digestive tract. MJAFI, 62, 123—128.

13. Mondal, N. K., Das, D., Mukherjee, B., Ray, M. R., 2011: Upregulation of AgNOR expression in epithelial cells and neutrophils in the airways and leukocytes in the peripheral blood of women chronically exposed to biomass smoke. Analyt. Quant. Cytol. Histol., 33, 50—59.

14. Ogunsola, J., Antia, R. E., 2018: Adaptation of a modified agyrophil technique to canine peripheral blood. Open Vet. J., 8, 182—185.

15. Parveen, S., Bukhari, M. H., Khan, S. A., Naveed, I. A., Chaudhry, N. A., 2006: AgNOR stain in normal cirrhotic and carcinomatous liver. Biomedica, 22, 59—61.

16. Ploton, D., Menager, M., Jeannesson, P., Himber, G., Pigeon, F., Adnet J. J., 1986: Improvement in the staining and visualization of the agyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem. J., 18, 5—14.

17. Pogorelov, V. M., Kozinets, G. I., Mikhailova, E. A., Medovy, V. S., Verdenskaya, N. V., Ivanova, I. A., et al., 1996: Discrimination and automated classification of apoptotic lymphocytes in silver-stained (AgNOR reaction) peripheral blood smears from patients with severe aplastic anaemia. Analyt. Quant. Cytol. Histol., 18, 92—93.

18. Rodrigues, O. R., Antonangelo, L., Yagi, N., Minamoto, H., Schmidt, A. F., et al., 1997: Prognostic significance of agyrophilic nucleolar organizer region in resected non-small cell lung cancer. Japanese J. Clin. Oncol., 27, 298—304.

19. Salehinejad, J., Kalantari, M. R., Omidi, A. A., Zare, R., 2007: Evaluation of AgNOR staining of exfoliative cytology of normal oral (buccal) mucosa: Effect of smoking. J. Mashdad Dental Sch., 31, 22—24.

20. Sur, E., Celik, I., Oznurlu, Y., Faruk-Aydin, M., Sen, I., Ozparlak, H., 2003: Enzyme histochemistry and AgNOR numbers in the peripheral blood leukocytes of 6 month-old Kangal-bred Anatolian shepherd dogs. Revue de Médecine Vétérinaire, 154, 591—598.

21. Trere, D., 2000: AgNOR quantitation and staining. Micron, 31, 127—131.

22. Vajdovich, P., Psader, R., Toth, Z. A., Perge, E., 2004: Use of the agyrophilic nucleolar region for cytologic and histologic examination of lymph nodes in dogs. Vet. Pathol., 41, 338—345.

23. Van Belle, S. J. P., Cocquyt, V., 2003: Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Critical Rev. Oncol./Hematol., 47, 1—11.

24. Wang, J. Y., Rong, T. H., Liang, Y. R., Long, H., Chen, Q. L., Ma, G. W., 2004: Diagnostic application of detecting AgNOR in peripheral blood T lymphocytes in patients with esophageal carcinoma. Ai Zheng, 23, 577—580.

25. Yasunaga, Y., Shin, M., Miki, T., Okuyama, A., and Aozasa, K., 1998: Prognostic factors of renal cell carcinoma: A multi-variate analysis. J. Surgical Oncol., 68, 11—18.

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 69 69 9
PDF Downloads 51 51 6